Tag: CenterLab

CenterLab’s anti-diabetic drug candidate CS02 meets primary endpoint in phase 2 trial

pharmanewsdaily- July 11, 2020

Taiwanese pharma company Center Laboratories (CenterLab) said that its anti-diabetic drug candidate CS02 has met the primary endpoint of a phase 2 clinical trial. According ... Read More